Log In or Create Account

CROI
Conference on Bacteriophages
RWHAP Clinical Conference
Podcasts
Slides
Question of the Week
Donate
Contact

Advanced Search

CME Courses
CME Webinars
Dialogues
Topics In Antiviral Medicine
HIV Drug Resistance
Fellow Resources
About

Laura W. Cheever, MD, ScM

Laura W. Cheever, MD, ScM

HIV/AIDS Bureau, The Health Resources and Services Administration

Rockville, MD

Associate Administrator

Rockville, MD

131 Steuart St, Suite 500, San Francisco, CA 94105

Phone: (415) 544-9400 | info@iasusa.org

Home
Activities
Resources
About
Contact
Login
Careers
Donate
Website Policies

© 2025 International Antiviral Society–USA. All Rights Reserved.

CROI
Conference on Bacteriophages
RWHAP Clinical Conference
Podcasts
Slides
Question of the Week
Donate
Contact
CME Courses
CME Webinars
Dialogues
Topics In Antiviral Medicine
HIV Drug Resistance
Fellow Resources
About

Practice Question of the Week

April 21, 2025: Bacteriophages for Therapy of Nontuberculous Mycobacterium Infections

Which of the following is a substantial limitation to the broad use of bacteriophages for therapy of nontuberculous mycobacterium (NTM) infections?
- A. There are no bacteriophages available for treating NTM infections
- B. Bacteriophages capable of infecting NTM strains exist but they do not kill their bacterial hosts
- C. Bacteriophages cannot be used therapeutically in combination with antibiotics
- D. Currently available bacteriophages have very narrow preferences for NTM clinical isolates

Register for the Conference

Listen to the Podcast

View Archived Questions